Warning: From May 1st, these medical people will be banned from the train
Medical Network March 20th May 1st, untrustworthy drug companies responsible for travel restrictions on the use of trains and aircraft!
Recently, the National Development and Reform Commission, the Civil Aviation Administration, the Railway Corporation and other departments jointly issued a number of relevant opinions, and within a certain period of time, appropriate restrictions were placed on the use of trains and civil aircraft by certain serious defaulters. The opinions have been implemented since May 1, 2018.
The "Opinions" pointed out that for those responsible for serious violations of trustworthy behavior in other areas, they will restrict the use of high-grade seats on trains, including soft trains for trains, all seats for G-head trains, and seats for seats of other EMU trains.
At the same time, restrictions on the use of civil aircraft are valid for one year. Within the validity period, if the legal obligations are fulfilled, the relevant department shall remove the list within 7 working days.
Responsible persons for related acts of dishonesty include:
The party who has the ability to perform but refuses to perform major tax violations;
In the field of fiscal fund management and use, there are frauds that falsely report fraudulently, fraudulently taking frauds, interception and misappropriation, and arrears of serious untrustworthy behaviors that are in arrears to international financial organizations and foreign governments;
In the field of social insurance, there are persons who commit serious acts of dishonesty in the following situations: The employer fails to participate in social insurance according to the relevant regulations and refuses to make corrections; The employer does not truthfully report the social insurance payment base and refuses to make corrections; Social insurance premiums must be paid Those who have the ability to pay but refuse to pay; conceal, transfer, invade, misappropriate social insurance funds or operate in violation of regulations; fraudulently forge social insurance benefits by fraudulent proof materials or other means; social insurance service agencies violate service agreements or related Provisions; Refusal to assist the social insurance administrative department in the investigation and verification of accidents and problems;
Securities and futures are illegally punished with fines and no overdue payment; Overdue entities of listed companies do not perform public commitments within the prescribed time limit;
The people’s courts have taken measures to restrict consumption in accordance with relevant regulations, or have included the list of untrusted trusts according to law.
Any other person who is responsible for serious acts of dishonesty in the high-level seats on trains as determined by the relevant department, and the relevant department has joined this document, should clarify the method by modifying this document.
As early as June 12, 2016, the State Council issued guidance on the establishment of a joint trustworthiness and joint incentive system for untrustworthy joint punishment and accelerating the development of social integrity. Article XI of the State Council [2016] No. 33. [2016] No. 33 It is proposed to strengthen the market-based restraint and punishment of dishonesty:
For serious untrustworthy entities, relevant departments and agencies should use a unified social credit code as an index to disclose relevant information in a timely manner so that the market can identify untrustworthy behaviors and prevent credit risks.
Urge relevant enterprise Individuals and individuals fulfill their statutory obligations, impose restrictions on exiting and restricting the purchase of immovable property, perform high-class trains and seats, travel holidays, stay in hotels and other high-consumption activities, etc. for those who have the ability to perform but refuse to perform. ;
Supporting credit information agencies to collect information on serious dishonesty, including credit records and credit reports;
Guide commercial banks, securities and futures operating agencies, insurance companies and other financial institutions in accordance with the principle of risk pricing, to increase the interest rate on loans and property insurance premium rates for serious untrustworthy entities, or to provide loans, sponsorship, underwriting, insurance and other services to them.
On March 7th this year, the Food and Drug Administration of Xiaogan City in Hubei issued “Xiaogan City drug Measures for the Assessment and Application of Business Credit Ratings (Trial) (hereinafter referred to as "Application Measures").
The "Applied Measures" shall come into force on March 10, 2018, and the period of validity shall be 2 years. Among them, Article 8 stipulates that one of the following situations is determined by a pharmaceutical company as a serious untrustworthy grade:
(I) Violation of Drug Supervision and Management Law Regulation , The license was revoked according to law;
(2) Being subjected to administrative punishment by the supervisory and administrative department for ordering suspension of business due to serious violations;
(iii) Inclusion of other departments in the joint disciplinary list;
(4) Being penalized by the supervisory and administrative department for its illegal acts;
(5) Counterfeit alteration administrative licenses, registration certificates, exit-entry quarantine certificates, approval certification documents, inspection reports, etc. When applying for an administrative license, providing false certification materials or concealing facts to the food and drug supervision and administration department;
(6) Responsible persons and directly responsible persons are criminally dealt with due to drug safety violations;
(vii) Others have subjective intent, sales fake Inferior drug The goods are in bad circumstances and are seriously hazardous.
The "Applying Measures" stipulates that the following measures can be taken for untrustworthy pharmaceutical companies:
(1) It will be listed as the focus of supervision and inspection, and increase daily supervision, follow-up inspections, and the frequency of flight inspections;
(b) interviewing business leaders;
(3) Announce to the public its credit rating and violations of laws and regulations;
(iv) Other measures prescribed by laws and regulations.
For seriously drug-losing drug companies, the following measures can also be taken:
(1) Restricted to engage in pharmaceutical business activities within a certain period of time;
(2) Ordering regular self-inspection of drug safety;
(iii) Including it into the 'black list' management of food and drug safety, and implementing joint disciplinary action on them;
(iv) Other measures prescribed by laws and regulations.
As can be seen from the above documents, from the whole industry to medicine Industry, the integrity system is gradually building, pharmaceutical companies Lai Lai will face 'a loss of trust, limited everywhere' of a large pattern of credit disciplinary.